Evidence map›Paper›PMID 37987767›Full record

ArticleAnalytical and bioanalytical chemistry2024

Paving the way for new and challenging matrix reference materials-particle suspensions at the core of material processing providing RMs for method development and method validation.

Håkan Emteborg, John Seghers, Silvia García-Ruiz, Saioa Elordui-Zapatarietxe, Andreas Breidbach, Kamel Labibes, Jean Charoud-Got, Robert Koeber

Open access · hybridAbstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Reference materials for food authentication.Analytical and bioanalytical chemistry · 2025
    Review
  4. Reference materials in analytical chemistry.Analytical and bioanalytical chemistry · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Håkan EmteborgEuropean Commission, Joint Research Centre (JRC), Geel, Belgium. hakan.emteborg@ec.europa.eu.ORCID http://orcid.org/0000-0003-2549-7255
John SeghersEuropean Commission, Joint Research Centre (JRC), Geel, Belgium.
Silvia García-RuizEuropean Commission, Joint Research Centre (JRC), Geel, Belgium.
Saioa Elordui-ZapatarietxeDiputación Foral de Bizkaia, Bilbao, Spain.
Andreas BreidbachEuropean Commission, Joint Research Centre (JRC), Geel, Belgium.
Kamel LabibesAyam Sailing Europe, ASE, La Louvière, Belgium.
Jean Charoud-GotEuropean Commission, Joint Research Centre (JRC), Geel, Belgium.
Robert KoeberEuropean Commission, Joint Research Centre (JRC), Geel, Belgium.
European Commission · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sufficient homogeneity of the certified parameter(s) over the whole fill series of a matrix reference material (RM) is a fundamental quality criterion. In practice, the heterogeneity of the target parameter is evaluated, whereby a relative value can be calculated of how much the target parameter is varying over the RM-batch. A high degree of homogeneity (low heterogeneity) is an inherent quality mark of a good RM. Here, we report how challenging matrix RMs were produced by using particle suspensions at the core of the material processing step. The examples of matrix RMs produced span from whole water reference materials for persistent organic pollutants, PM

Indexed as

Certified reference materialHeterogeneityHomogeneityMethod validationMicroplasticsParticlesReference materialRepeatabilitySpikingSuspensions

Identifiers

PMID37987767
PMCPMC10950969
OpenAlexW4388850557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.